These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 20618873)
61. Osimertinib-induced cardiac failure with QT prolongation and torsade de pointes in a patient with advanced pulmonary adenocarcinoma. Ikebe S; Amiya R; Minami S; Ihara S; Higuchi Y; Komuta K Int Cancer Conf J; 2021 Jan; 10(1):68-71. PubMed ID: 33489705 [TBL] [Abstract][Full Text] [Related]
62. Intracoronary electrocardiogram during torsade des pointes secondary to intracoronary papaverine. Jain A; Jenkins MG Cathet Cardiovasc Diagn; 1989 Dec; 18(4):255-7. PubMed ID: 2605630 [TBL] [Abstract][Full Text] [Related]
63. Allergic reaction to contrast medium following gastric band adjustment. Dewachter P; Mouton-Faivre C Obes Surg; 2007 Oct; 17(10):1413-5. PubMed ID: 18000734 [TBL] [Abstract][Full Text] [Related]
64. A rare case of acute contrast-induced sialadenitis after percutaneous coronary intervention. Shacham Y; Havakuk O; Roth A Isr Med Assoc J; 2013 Oct; 15(10):652-3. PubMed ID: 24266096 [No Abstract] [Full Text] [Related]
65. Ultrasound findings of iodide mumps. Park SJ; Hong HS; Lee HK; Joh JH; Cha JG; Kim HC Br J Radiol; 2005 Feb; 78(926):164-5. PubMed ID: 15681332 [TBL] [Abstract][Full Text] [Related]
66. Evaluation of renal function. Becker JA Radiology; 1991 May; 179(2):337-8. PubMed ID: 2014272 [No Abstract] [Full Text] [Related]
67. Physicians' and pharmacists' acceptance of online, real-time "drug combinations to avoid" messages. Kim DS; Jeon HL; Lee S; Je NK Int J Clin Pharmacol Ther; 2015 Sep; 53(9):712-21. PubMed ID: 26104037 [TBL] [Abstract][Full Text] [Related]
68. Skin reaction to contrast medium. Gonzalo-Garijo MA; de Argila D; Pimentel JJ; Alejo M; García-Menaya JM Allergy; 1997 Aug; 52(8):875-6. PubMed ID: 9284992 [No Abstract] [Full Text] [Related]
69. [QT prolongation and torsade de pointes tachycardia during therapy with maprotiline. Differential diagnostic and therapeutic aspects]. Lentini S; Rao ML; Schröder R; Lüderitz B; Bauriedel G Dtsch Med Wochenschr; 2001 Dec; 126(49):1396-400. PubMed ID: 11740632 [TBL] [Abstract][Full Text] [Related]
70. QT prolongation and Torsades de Pointes in patients previously treated with anthracyclines. Arbel Y; Swartzon M; Justo D Anticancer Drugs; 2007 Apr; 18(4):493-8. PubMed ID: 17351403 [TBL] [Abstract][Full Text] [Related]
71. QT interval prolongation and torsade de pointes. Patanè S; Marte F; Di Bella G Int J Cardiol; 2009 Jan; 131(2):e51-3. PubMed ID: 17689729 [TBL] [Abstract][Full Text] [Related]
72. Torsade de pointes induced by ioxaglate intracoronary injection in patients with pre-existent drug-induced QT prolongation: case reports and review of literature. Andréjak M; Leborgne L; Tribouilloy C; Andréjak MT; Caron J Fundam Clin Pharmacol; 2011 Jun; 25(3):296-9. PubMed ID: 20618873 [TBL] [Abstract][Full Text] [Related]
73. Drug-induced long QT and torsade de pointes: recent advances. Kannankeril PJ; Roden DM Curr Opin Cardiol; 2007 Jan; 22(1):39-43. PubMed ID: 17143043 [TBL] [Abstract][Full Text] [Related]